Nuvation Bio (NUVB) Income towards Parent Company (2023 - 2025)
Historic Income towards Parent Company for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to -$55.8 million.
- Nuvation Bio's Income towards Parent Company fell 3538.46% to -$55.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$217.5 million, marking a year-over-year increase of 5914.19%. This contributed to the annual value of -$567.9 million for FY2024, which is 64924.01% down from last year.
- Latest data reveals that Nuvation Bio reported Income towards Parent Company of -$55.8 million as of Q3 2025, which was down 3538.46% from -$59.0 million recorded in Q2 2025.
- In the past 5 years, Nuvation Bio's Income towards Parent Company ranged from a high of -$13.8 million in Q4 2023 and a low of -$462.5 million during Q2 2024
- In the last 3 years, Nuvation Bio's Income towards Parent Company had a median value of -$41.2 million in 2024 and averaged -$73.8 million.
- Per our database at Business Quant, Nuvation Bio's Income towards Parent Company crashed by 214075.58% in 2024 and then soared by 8724.15% in 2025.
- Nuvation Bio's Income towards Parent Company (Quarter) stood at -$13.8 million in 2023, then tumbled by 258.63% to -$49.4 million in 2024, then decreased by 12.84% to -$55.8 million in 2025.
- Its Income towards Parent Company stands at -$55.8 million for Q3 2025, versus -$59.0 million for Q2 2025 and -$53.2 million for Q1 2025.